Posttranscriptional regulation of uridine diphosphate glucuronosyltransferases

Bibliography

• Dutton G. Glucuronidation of drugs and other compounds. CRC Press; Boca Raton, FL: 1980
   Google Scholar
• Mackenzie PI, Bock KW, Burchell B, et al. Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenet Genomics 2005;677-85
   PubMed Web of Science ®Google Scholar
• Radominska-Pandya A, Czernik PJ, Little JM, et al. Structural and functional studies of UDP-glucuronosyl transferases. Drug Metab Rev 1999;31:817-99
   PubMed Web of Science ®Google Scholar
• Tukey RH, Strassburg CP. Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Ann Rev Pharmacol Toxicol 2000;40:581-616
   PubMed Web of Science ®Google Scholar
• Sallustio BC. Acyl Glucuronides as toxic intermediates. In: Hodgson WC, Lioacono RE, editors. Australasian Society for Clininal and Experimental Pharmacology and Toxicology. 2000 December 2000 ASCEPT society; Newcastle, Australia: 2000. p. 60
   Google Scholar
• Court M. Isoform selective probe substrates for in vitro studies of human UDP-glucuronosyltransferases. Methods Enzymol 2005;400:104-16
   PubMed Web of Science ®Google Scholar
• Tukey R, Strassburg C, Mackenzie P. Pharmacogenomics of human UDP-glucuronosyltransferases and irinotecan toxicity. Mol Pharmacol 2002;62:446-50
   PubMed Web of Science ®Google Scholar
• Evans WE, Relling M. Pharmacogenomics: translating functional genomics into rational therapeutics. Science 1999;286:487-91
   PubMed Web of Science ®Google Scholar
• Burchell B, Brierley CH, Rance D. Specificity of human UDP-glucuronosyltransferases and xenobiotic glucuronidation. Life Sci 1995;57:1819-31
   PubMed Web of Science ®Google Scholar
• Guillemette C, Lévesque E, Harvey M, et al. UGT genomic diversity: beyond gene duplication. Drug Metab Rev 2010;42:24-44
   PubMed Web of Science ®Google Scholar
• Hu D, Meech R, McKinnon R, et al. Transcriptional regulation of human UDP-glucuronosyltransferase genes. Drug Metab Rev 2014;46:421-58
   PubMed Web of Science ®Google Scholar
• Bock K. Human UDP-glucuronosyltransferases: feedback loops between substrates and ligands of their transcription factors. Biochem Pharmacol 2012;84:1000-6
   PubMed Web of Science ®Google Scholar
• Bock K. Functions and transcriptional regulation of adult human hepatic UDP-glucuronosyl-transferases (UGTs): mechanisms responsible for interindividual variation of UGT levels. Biochem Pharmacol 2010;80:771-7
   PubMed Web of Science ®Google Scholar
• Yasar U, Greenblatt DJ, Guillemette C, et al. Evidence for regulation of UDP-glucuronosyltransferase (UGT) 1A1 protein expression and activity via DNA methylation in healthy human livers. J Pharm Pharmacol 2013;65:874-83
   PubMed Web of Science ®Google Scholar
• Oda S, Fukami T, Yokoi T, et al. Epigenetic regulation is a crucial factor in the repression of UGT1A1 expression in the human kidney. Drug Metab Dispos 2013;41:1738-43
   PubMed Web of Science ®Google Scholar
• Oda S, Fukami T, Yokoi T, et al. Epigenetic regulation of the tissue-specific expression of human UDP-glucuronosyltransferase (UGT) 1A10. Biochem Pharmacol 2014;87:660-7
   PubMed Web of Science ®Google Scholar
• Mackenzie PI, Hu DG, Gardner-Stephen DA. The regulation of UDP-glucuronosyltransferase genes by tissue-specific and ligand-activated transcription factors. Drug Metab Rev 2010;42:99-109
   PubMed Web of Science ®Google Scholar
• Meech R, Mackenzie PI. UGT3A: novel UDP-glycosyltransferases of the UGT superfamily. Drug Metab Rev 2010;42:45-54
   PubMed Web of Science ®Google Scholar
• Rowland A, Miners JO, Mackenzie PI. The UDP-glucuronosyltransferases: their role in drug metabolism and detoxification. Int J Biochem Cell Biol 2013;45:1121-32
   PubMed Web of Science ®Google Scholar
• Gong Q, Cho J, Huang T, et al. Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. Pharmacogenetics 2001;11:357-68
   PubMedGoogle Scholar
• Caspersen C, Reznik B, Weldy P, et al. Molecular cloning of the baboon UDP-glucuronosyltransferase 1A gene family: evolution of the primate UGT1 locus and relevance for models of human drug metabolism. Pharmacogenet Genomics 2007;17:11-24
   PubMed Web of Science ®Google Scholar
• Owens I, Basu N, Banerjee R. UDP-glucuronosyltransferases: gene structures of UGT1 and UGT2 families. Methods Enzymol 2005;400:1-22
   PubMed Web of Science ®Google Scholar
• Mackenzie PI, Gregory PA, Gardner-Stephen DA, et al. Regulation of UDP glucuronosyltransferase genes. Curr Drug Metab 2003;4:249-57
   PubMed Web of Science ®Google Scholar
• Mackenzie PI, Gregory PA, Lewinsky RH, et al. Polymorphic variations in the expression of the chemical detoxifying UDP glucuronosyltransferases. Toxicol Appl Pharmacol 2005;207:S77-83
   PubMedGoogle Scholar
• Sneitz N, Court M, Zhang X, et al. Human UDP-glucuronosyltransferase UGT2A2: cDNA construction, expression, and functional characterization in comparison with UGT2A1 and UGT2A3. Pharmacogenet Genomics 2009;19:923-34
   PubMed Web of Science ®Google Scholar
• Bushey RT, Dluzen D, Lazarus P. Importance of UDP-glucuronosyltransferases 2A2 and 2A3 in tobacco carcinogen metabolism. Drug Metab Dispos 2013;41:170-9
   PubMed Web of Science ®Google Scholar
• Mackenzie PI, Rogers A, Treloar J, et al. Identification of UDP glycosyltransferase 3A1 as a UDP N-acetylglucosaminyltransferase. J Biol Chem 2008;283:36205-10
   PubMed Web of Science ®Google Scholar
• MacKenzie P, Rogers A, Elliot D, et al. The novel UDP glycosyltransferase 3A2: cloning, catalytic properties, and tissue distribution. Mol Pharmacol 2011;79:472-8
   PubMed Web of Science ®Google Scholar
• Meech R, Rogers A, Zhuang L, et al. Identification of residues that confer sugar selectivity to UDP-glycosyltransferase 3A (UGT3A) enzymes. J Biol Chem 2012;287:24122-30
   PubMed Web of Science ®Google Scholar
• Bosio A, Binczek E, Le Beau M, et al. The human gene CGT encoding the UDP-galactose ceramide galactosyl transferase (cerebroside synthase): cloning, characterization, and assignment to human chromosome 4, band q26. Genomics 1996;34:69-75
   PubMed Web of Science ®Google Scholar
• Meech R, Mubarokah N, Shivasami A, et al. A novel function for UDP glycosyltransferase 8: galactosidation of bile acids. Mol Pharmacol 2015;87:442-50
   PubMed Web of Science ®Google Scholar
• Bock K. Vertebrate UDP-glucuronosyltransferases: functional and evolutionary aspects. Biochem Pharmacol 2003;66:691-6
   PubMed Web of Science ®Google Scholar
• Shrestha B, Reed J, Starks P, et al. Evolution of a major drug metabolizing enzyme defect in the domestic cat and other felidae: phylogenetic timing and the role of hypercarnivory. PLoS One 2011;6:e18046
   PubMed Web of Science ®Google Scholar
• McCarroll S, Hadnott T, Perry G, et al. Common deletion polymorphisms in the human genome. Nat Genet 2006;38:86-92
   PubMed Web of Science ®Google Scholar
• Izukawa T, Nakajima M, Fujiwara R, et al. Quantitative analysis of UDP-glucuronosyltransferase (UGT) 1A and UGT2B expression levels in human livers. Drug Metab Dispos 2009;37:1759-68
   PubMed Web of Science ®Google Scholar
• Strassburg C, Strassburg A, Kneip S, et al. Developmental aspects of human hepatic drug glucuronidation in young children and adults. Gut 2002;50:259-65
   PubMed Web of Science ®Google Scholar
• Miyagi SJ, Collier AC. Pediatric development of glucuronidation: the ontogeny of hepatic UGT1A4. Drug Metab Dispos 2007;35:1587
   PubMed Web of Science ®Google Scholar
• Miyagi SJ, Collier AC. The development of UDP-glucuronosyltransferases 1A1 and 1A6 in the pediatric liver. Drug Metab Dispos 2011;39:912-19
   PubMed Web of Science ®Google Scholar
• Miyagi SJ, Milne AM, Coughtrie M, et al. The neonatal development of hepatic UGT1A9: implications of pediatric pharmacokinetics. Drug Metab Dispos 2012;40:1321-7
   PubMed Web of Science ®Google Scholar
• Sato Y, Nagata M, Tetsuka K, et al. Optimized methods for targeted peptide-based quantification of human uridine 5’-diphosphate-glucuronosyltransferases in biological specimens using liquid chromatography-tandem mass spectrometry. Drug Metab Dispos 2014;42:885-9
   PubMed Web of Science ®Google Scholar
• Hardwick RN, Ferreira DW, More VR, et al. Altered UDP-glucuronosyltransferase and sulfotransferase expression and function during progressive stages of human nonalcoholic fatty liver disease. Drug Metab Dispos 2013;41(3):554-61
   PubMed Web of Science ®Google Scholar
• Strassburg CP, Kneip S, Topp J, et al. Polymorphic gene regulation and interindividual variation of UDP-glucuronosyltransferase activity in human small intestine. J Biol Chem 2000;275(46):36164-71
   PubMed Web of Science ®Google Scholar
• Gregory PA, Lewinsky RH, Gardner-Stephen DA, PI M. Regulation of UDP glucuronosyltransferases in the gastrointestinal tract. Toxicol Appl Pharmacol 2004;199(3):354-63
   PubMed Web of Science ®Google Scholar
• Fisher MB, Paine MF, Strelevitz TJ, SA W. The role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism. Drug Metab Rev 2001;33(3-4):273-97
   PubMed Web of Science ®Google Scholar
• Ekström L, Johansson M, Rane A. Tissue distribution and relative gene expression of UDP-glucuronosyltransferases (2B7, 2B15, 2B17) in the human fetus. Drug Metab Dispos 2013;41(2):291-5
   PubMed Web of Science ®Google Scholar
• Grosse L, Pâquet S, Caron P, et al. Androgen glucuronidation: an unexpected target for androgen deprivation therapy, with prognosis and diagnostic implications. Cancer Res 2013;73(23):6963-71
   PubMed Web of Science ®Google Scholar
• Gauthier-Landry L, Bélanger A, Barbier B. Multiple roles for UDP-glucuronosyltransferase (UGT)2B15 and UGT2B17 enzymes in androgen metabolism and prostate cancer evolution. J Steroid Biochem Mol Biol 2015;145:187-92
   PubMed Web of Science ®Google Scholar
• Hum DW, Bélanger A, Lévesque E, et al. Characterization of UDP-glucuronosyltransferases active on steroid hormones. J Steroid Biochem Mol Biol 1999;69(1-6):413-23
   PubMed Web of Science ®Google Scholar
• Turgeon D, Carrier JS, Lévesque E, et al. Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members. Endocrinology 2001;142(2):778-87
   PubMed Web of Science ®Google Scholar
• Ouzzine M, Magdalou J, Burchell B, Fournel-Gigleux S. An internal signal sequence mediates the targeting and retention of the human UDP-glucuronosyltransferase 1A6 to the endoplasmic reticulum. J Biol Chem 1999;274(44):31401-9
   PubMed Web of Science ®Google Scholar
• Bock K, Kohle C. Topological aspects of oligomeric UDP-glucuronosyltransferases in endoplasmic reticulum membranes: advances and open questions. Biochem Pharmacol 2009;77(9):1458-65
   PubMed Web of Science ®Google Scholar
• Radominska-Pandya A, Bratton SM, Redinbo MR, Miley MJ. The crystal structure of human UDP-glucuronosyltransferase 2B7 C-terminal end is the first mammalian UGT target to be revealed: the significance for human UGTs from both the 1A and 2B families. Drug Metab Rev 2010;42(1):133-44
   PubMed Web of Science ®Google Scholar
• Miley M, Zielinska A, Keenan J, et al. Crystal structure of the cofactor-binding domain of the human phase II drug-metabolism enzyme UDP-glucuronosyltransferase 2B7. J Mol Biol 2007;369(2):498-511
   PubMed Web of Science ®Google Scholar
• Ouzzine M, Magdalou J, Burchell B, Fournel-Gigleux S. Expression of a functionally active human hepatic UDP-glucuronosyltransferase (UGT1A6) lacking the N-terminal signal sequence in the endoplasmic reticulum. FEBS Lett 1999;454(3):187-91
   PubMed Web of Science ®Google Scholar
• Goto S, Taniguchi M, Muraoka M, et al. UDP-sugar transporter implicated in glycosylation and processing of Notch. Nat Cell Biol 2001;3(9):816-22
   PubMed Web of Science ®Google Scholar
• Rowland A, Mackenzie P, Miners J. Transporter-mediated uptake of UDP-glucuronic acid by human liver microsomes: assay conditions, kinetics, and inhibition. Drug Metab Dispos 2015;43:147-53
   PubMed Web of Science ®Google Scholar
• Révész K, Tóth B, Staines AG, et al. Luminal accumulation of newly synthesized morphine-3-glucuronide in rat liver microsomal vesicles. Biofactors 2013;39:271-8
   PubMed Web of Science ®Google Scholar
• Guéraud F, Paris A. Glucuronidation: a dual control. Gen Pharmacol 1998;31:683-8
   PubMedGoogle Scholar
• Fisher MB, Campanale K, Ackermann BL, et al. In vitro glucuronidation using human liver microsomes and the pore-forming peptide alamethicin. Drug Metab Dispos 2000;28:560-6
   PubMed Web of Science ®Google Scholar
• Zakim D, Dannenberg A. How does the microsomal membrane regulate UDP-glucuronosyltransferases? Biochem Pharmacol 1992;43:1385-93
   PubMed Web of Science ®Google Scholar
• Meech R, Mackenzie P. Structure and function of uridine diphosphate glucuronosyltransferases. Clin Exp Pharmacol Physiol 1997;24:907-15
   PubMed Web of Science ®Google Scholar
• Selva E, Hong K, Baeg G, et al. Dual role of the fringe connection gene in both heparan sulphate and fringe-dependent signalling events. Nat Cell Biol 2001;3:809-15
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Sleeman JE, Coughtrie MW, et al. Molecular and functional characterization of microsomal UDP-glucuronic acid uptake by members of the nucleotide sugar transporter (NST) family. Biochem J 2006;400:281-9
   PubMed Web of Science ®Google Scholar
• Ishii Y, An K, Nishimura Y, et al. ATP serves as an endogenous inhibitor of UDP-glucuronosyltransferase (UGT): a new insight into the latency of UGT. Drug Metab Dispos 2012;40:2081-9
   PubMed Web of Science ®Google Scholar
• Ishii Y, Nurrochmad A, Yamada H. Modulation of UDP-glucuronosyltransferase activity by endogenous compounds. Drug Metab Pharmacokinet 2010;25:134-48
   PubMed Web of Science ®Google Scholar
• Imperiali B, O’Connor S. Effect of N-linked glycosylation on glycopeptide and glycoprotein structure. Curr Opin Chem Biol 1999;3:643-9
   PubMed Web of Science ®Google Scholar
• Nakajima M, Koga T, Sakai H, et al. N-Glycosylation plays a role in protein folding of human UGT1A9. Biochem Pharmacol 2010;79:1165-72
   PubMed Web of Science ®Google Scholar
• Barbier O, Girard C, Breton R, et al. N-glycosylation and residue 96 are involved in the functional properties of UDP-glucuronosyltransferase enzymes. Biochemistry 2000;39:11540-52
   PubMed Web of Science ®Google Scholar
• Nagaoka K, Hanioka N, Ikushiro S, et al. The effects of N-glycosylation on the glucuronidation of zidovudine and morphine by UGT2B7 expressed in HEK293 cells. Drug Metab Pharmacokinet 2012;27:388-97
   PubMed Web of Science ®Google Scholar
• Freeze H, Westphal V. Balancing N-linked glycosylation to avoid disease. Biochimie 2001;83:791-9
   PubMed Web of Science ®Google Scholar
• Freeze H. Understanding human glycosylation disorders: biochemistry leads the charge. J Biol Chem 2013;288:6936-45
   PubMed Web of Science ®Google Scholar
• Fremont J, Wang R, King CD. Coimmunoprecipitation of UDP-glucuronosyltransferase isoforms and cytochrome P450 3A4. Mol Pharmacol 2005;67:260-2
   PubMed Web of Science ®Google Scholar
• Ferrell J, Ha S. Ultrasensitivity part II: multisite phosphorylation, stoichiometric inhibitors, and positive feedback. Trends Biochem Sci 2014;39:556-69
   PubMed Web of Science ®Google Scholar
• Basu N, Kole L, Owens I. Evidence for phosphorylation requirement for human bilirubin UDP-glucuronosyltransferase (UGT1A1) activity. Biochem Biophys Res Commun 2003;303:98-104
   PubMed Web of Science ®Google Scholar
• Basu N, Kovarova M, Garza A, et al. Phosphorylation of a UDP-glucuronosyltransferase regulates substrate specificity. Proc Natl Acad Sci USA 2005;102:6285-90
   PubMed Web of Science ®Google Scholar
• Basu N, Kole L, Basu M, et al. The major chemical-detoxifying system of UDP-glucuronosyltransferases requires regulated phosphorylation supported by protein kinase C. J Biol Chem 2008;283:23048-61
   PubMed Web of Science ®Google Scholar
• Basu NK, Kole L, Owens IS. Evidence for phosphorylation requirement for human bilirubin UDP-glucuronosyltransferase (UGT1A1) activity. Biochem Biophys Res Commun 2003;303(1):98-104
   PubMed Web of Science ®Google Scholar
• Chakraborty S, Basu N, Jana S, et al. Protein kinase Calpha and Src kinase support human prostate-distributed dihydrotestosterone-metabolizing UDP-glucuronosyltransferase 2B15 activity. J Biol Chem 2012;287:24387-96
   PubMed Web of Science ®Google Scholar
• Vaidyanathan K, Durning S, Wells L. Functional O-GlcNAc modifications: implications in molecular regulation and pathophysiology. Crit Rev Biochem Mol Biol 2014;49:140-63
   PubMed Web of Science ®Google Scholar
• Zhang Z, Wu J, Hait W, et al. Regulation of the stability of P-glycoprotein by ubiquitination. Mol Pharmacol 2004;66:395-403
   PubMed Web of Science ®Google Scholar
• Tsoutsikos P, Miners J, Stapleton A, et al. Evidence that unsaturated fatty acids are potent inhibitors of renal UDP-glucuronosyltransferases (UGT): kinetic studies using human kidney cortical microsomes and recombinant UGT1A9 and UGT2B7. Biochem Pharmacol 2004;67:191-9
   PubMed Web of Science ®Google Scholar
• Rowland A, Elliot DJ, Knights KM, et al. The “albumin effect” and in vitro-in vivo extrapolation: sequestration of long-chain unsaturated fatty acids enhances phenytoin hydroxylation by human liver microsomal and recombinant cytochrome P450 2C9. Drug Metab Dispos 2008;36:870-7
   PubMed Web of Science ®Google Scholar
• Pienimaeki-Roemer A, Ruebsaamen K, Boettcher A, et al. Stored platelets alter glycerophospholipid and sphingolipid species, which are differentially transferred to newly released extracellular vesicles. Transfusion 2013;53:612-26
   PubMed Web of Science ®Google Scholar
• Manevski N, Moreolo P, Yli-Kauhaluoma J, et al. Bovine serum albumin decreases Km values of human UDP-glucuronosyltransferases 1A9 and 2B7 and increases Vmax values of UGT1A9. Drug metab Dispos 2011;39:2117-29
   PubMed Web of Science ®Google Scholar
• Rowland A, Gaganis P, Elliot DJ, et al. Binding of inhibitory fatty acids is responsible for the enhancement of UDP-glucuronosyltransferase 2B7 activity by albumin: implications for in vitro-in vivo extrapolation. J Pharmacol Exp Ther 2007;321:137-47
   PubMed Web of Science ®Google Scholar
• Nishimura Y, Maeda S, Ikushiro S, et al. Inhibitory effects of adenine nucleotides and related substances on UDP- glucuronosyltransferase: structure- effect relationships and evidence for an allosteric mechanism. Biochim Biophys Acta 2007;1770:1557-66
   PubMed Web of Science ®Google Scholar
• Csala M, Banhegyi G, Kardon T, et al. Inhibition of glucuronidation by an acyl-CoA-mediated indirect mechanism. Biochem Pharmacol 1996;52:1127-31
   PubMed Web of Science ®Google Scholar
• Yamashita A, Nagatsuka T, Watanabe M, et al. Inhibition of UDP-glucuronosyltransferase activity by fatty acyl-CoA. Kinetic studies and structureactivity relationship. Biochem Pharmacol 1997;53:561-70
   PubMed Web of Science ®Google Scholar
• Okamura K, Ishii Y, Ikushiro S, et al. Fatty acyl-CoA as an endogenous activator of UDP-glucuronosyltransferases. Biochem Biophys Res Commun 2006;345:1649-56
   PubMed Web of Science ®Google Scholar
• Krcmery M, Zakim D. Effects of oleoyl-CoA on the activity and functional state of UDP-glucuronosyltransferase. Biochem Pharmacol 1993;46:897-904
   PubMed Web of Science ®Google Scholar
• Bossuyt X, Blanckaert N. Mechanism of stimulation of microsomal UDP-glucuronosyltransferase by UDP-N-acetylglucosamine. Biochem J 1995;305:321-8
   PubMed Web of Science ®Google Scholar
• Bossuyt X, Blanckaert N. Uridine diphosphoxylose enhances hepatic microsomal UDP-glucuronosyltransferase activity by stimulating transport of UDP-glucuronic acid across the endoplasmic reticulum membrane. Biochem J 1996;315:189-93
   PubMed Web of Science ®Google Scholar
• Hauser S, Ransil B, Ziurys J, et al. Interaction of uridine 5’-diphosphoglucuronic acid with microsomal UDP-glucuronosyltransferase in primate liver: the facilitating role of uridine 5’-diphospho-N-acetylglucosamine. Biochim Biophys Acta 1988;967:141-8
   PubMed Web of Science ®Google Scholar
• Pogell B, Leloir L. Nucleotide activation of liver microsomal glucuronidation. J Biol Chem 1961;236:293-8
   PubMed Web of Science ®Google Scholar
• MacKenzie PI, Rogers A, Elliot DJ, et al. The novel UDP glycosyltransferase 3A2: cloning, catalytic properties, and tissue distribution. Mol Pharmacol 2011;79:472-8
   PubMed Web of Science ®Google Scholar
• Chau N, Elliot D, Lewis B, et al. Morphine glucuronidation and glucosidation represent complementary metabolic pathways that are both catalyzed by UDP-glucuronosyltransferase 2B7: kinetic, inhibition, and molecular modeling studies. J Pharmacol Exp Ther 2014;349(1):126-37
   PubMed Web of Science ®Google Scholar
• Zhou J, Tracy T, Remmel RP. Glucuronidation of dihydrotestosterone and trans-androsterone by recombinant UDP-glucuronosyltransferase (UGT) 1A4: evidence for multiple UGT1A4 aglycone binding sites. Drug Metab Dispos 2010;38:431-40
   PubMed Web of Science ®Google Scholar
• Mahajan M, Uttamsingh V, Gan L, et al. Identification and characterization of oxymetazoline glucuronidation in human liver microsomes: evidence for the involvement of UGT1A9. J Pharm Sci 2011;100:784-93
   PubMed Web of Science ®Google Scholar
• Hanioka N, Hayashi K, Shimizudani T, et al. Stereoselective glucuronidation of propranolol in human and cynomolgus monkey liver microsomes: role of human hepatic UDP-glucuronosyltransferase isoforms, UGT1A9, UGT2B4 and UGT2B7. Pharmacology 2008;82:293-303
   PubMed Web of Science ®Google Scholar
• Schwaninger A, Meyer M, Zapp J, et al. The role of human UDP-glucuronyltransferases on the formation of the ethylenedioxymethamphetamine (ecstasy) phase II metabolites R- and S-3-ethoxymethamphetamine 4-O-glucuronides. Drug Metab Dispos 2009;37:2212-20
   PubMed Web of Science ®Google Scholar
• Aprile S, Del Grosso E, Grosa G. Identification of the human UDP-glucuronosyltransferases involved in the glucuronidation of combretastatin A-4. Drug Metab Dispos 2010;38:1141-6
   PubMed Web of Science ®Google Scholar
• Hu N, Mei M, Ruan J, et al. Regioselective glucuronidation of oxyresveratrol, a natural hydroxystilbene, by human liver and intestinal microsomes and recombinant UGTs. Drug Metab Pharmacokinet 2014;29:229-36
   PubMed Web of Science ®Google Scholar
• Iwuchukwu O, Nagar S. Cis-resveratrol glucuronidation kinetics in human and recombinant UGT1A sources. Xenobiotica 2010;40:102-8
   PubMed Web of Science ®Google Scholar
• Zhou D, Guo J, Linnenbach A, et al. Role of human UGT2B10 in N-glucuronidation of tricyclic antidepressants, amitriptyline, imipramine, clomipramine, and trimipramine. Drug Metab Dispos 2010;38:863-70
   PubMed Web of Science ®Google Scholar
• Williams J, Ring B, Cantrell V, et al. Differential modulation of UDP-glucuronosyltransferase 1A1 (UGT1A1)-catalyzed estradiol-3-glucuronidation by the addition of UGT1A1 substrates and other compounds to human liver microsomes. Drug Metab Dispos 2002;30:1266-73
   PubMed Web of Science ®Google Scholar
• Mano Y, Usui T, Kamimura H. Effects of beta-estradiol and propofol on the 4-methylumbelliferone glucuronidation in recombinant human UGT isozymes 1A1, 1A8 and 1A9. Biopharm Drug Dispos 2004;25:339-44
   PubMed Web of Science ®Google Scholar
• Pfeiffer E, Treiling C, Hoehle S, et al. Isoflavones modulate the glucuronidation of estradiol in human liver microsomes. Carcinogenesis 2005;26:2172-8
   PubMed Web of Science ®Google Scholar
• Radominska-Pandya A, Bratton S, Little JM. A historical overview of the heterologous expression of mammalian UDP-glucuronosyltransferase isoforms over the past twenty years. Curr Drug Metab 2005;6:141-60
   PubMed Web of Science ®Google Scholar
• Ghosh S, Sappa LB, Kalpana G, et al. Homodimerization of human bilirubin-uridine-diphosphoglucuronate glucuronosyltransferase-1 (UGT1A1) and its functional implications. J Biol Chem 2001;276:42108-15
   PubMed Web of Science ®Google Scholar
• Ishii Y, Iwanaga M, Nishimura Y, et al. Protein-protein interactions between rat hepatic cytochromes P450 (P450s) and UDP-glucuronosyltransferases (UGTs): evidence for the functionally active UGT in P450-UGT complex. Drug Metab Pharmacokinet 2007;22:367-76
   PubMed Web of Science ®Google Scholar
• Lewis BC, Mackenzie PI, Miners JO. Homodimerization of UDP-glucuronosyltransferase 2B7 (UGT2B7) and identification of a putative dimerization domain by protein homology modeling. Biochem Pharmacol 2011;82:2016-23
   PubMed Web of Science ®Google Scholar
• Operaña T, Tukey R. Oligomerization of the UDP-glucuronosyltransferase 1A proteins: homo- and heterodimerization analysis by fluorescence resonance energy transfer and co-immunoprecipitation. J Biol Chem 2007;282:4821-9
   PubMed Web of Science ®Google Scholar
• Takeda S, Ishii Y, Iwanaga M, et al. Modulation of UDP-glucuronosyltransferase function by cytochrome P450: evidence for the alteration of UGT2B7-catalyzed glucuronidation of morphine by CYP3A4. Mol Pharmacol 2005;67:665-72
   PubMed Web of Science ®Google Scholar
• Taura KI, Yamada H, Hagino Y, et al. Interaction between cytochrome P450 and other drug-metabolizing enzymes: evidence for an association of CYP1A1 with microsomal epoxide hydrolase and UDP-glucuronosyltransferase. Biochem Biophys Res Commun 2000;273:1048-52
   PubMed Web of Science ®Google Scholar
• Ikushiro S, Emi Y, Iyanagi T. Protein-protein interactions between UDP-glucuronosyltransferase isozymes in rat hepatic microsomes. Biochemistry 1997;36:7154-61
   PubMed Web of Science ®Google Scholar
• Fujiwara R, Nakajima M, Yamanaka H, et al. Interactions between human UGT1A1, UGT1A4, and UGT1A6 affect their enzymatic activities. Drug Metab Dispos 2007;35:1781-7
   PubMed Web of Science ®Google Scholar
• Fujiwara R, Nakajima M, Oda S, et al. Interactions between human UDP-glucuronosyltransferase (UGT) 2B7 and UGT1A enzymes. J Pharm Sci 2010;99:442-54
   PubMed Web of Science ®Google Scholar
• Finel M, Kurkela M. The UDP-glucuronosyltransferases as oligomeric enzymes. Curr Drug Metab 2008;9:70-6
   PubMed Web of Science ®Google Scholar
• Achour B, Russell M, Barber J, et al. Simultaneous quantification of the abundance of several cytochrome P450 and uridine 5’-diphospho-glucuronosyltransferase enzymes in human liver microsomes using multiplexed targeted proteomics. Drug Metab Dispos 2014;42:500-10
   PubMed Web of Science ®Google Scholar
• Fallon J, Neubert H, Hyland R, et al. Targeted quantitative proteomics for the analysis of 14 UGT1As and -2Bs in human liver using Nano UPLC-MS/MS with selected reaction monitoring. J Proteome Res 2013;12:4402-13
   PubMed Web of Science ®Google Scholar
• Divakaran K, Hines R, McCarver D. Human hepatic UGT2B15 developmental expression. Toxicol Sci 2014;14:292-9
   Google Scholar
• Kawade N, Onishi S. The prenatal and postnatal development of UDP-glucuronyltransferase activity towards bilirubin and the effect of premature birth on this activity in human liver. Biochem J 1981;196:257-60
   PubMed Web of Science ®Google Scholar
• Onishi S, Kawade N, Itoh S, et al. Postnatal development of uridine diphosphate glucuronyltransferase activity towards bilirubin and 2-aminophenol in human liver. Biochem J 1979;184:705-7
   PubMed Web of Science ®Google Scholar
• Strassburg CP, Manns MP, Tukey RH. Differential down-regulation of the UDP-glucuronosyltransferase 1A locus is an early event in human liver and biliary cancer. Cancer Res 1997;57:2979-85
   PubMed Web of Science ®Google Scholar
• Tiribelli C, Ostrow JD. New Concepts in Bilirubin and Jaundice: report of the Third International Bilirubin Workshop, April 6-8, 1995, Trieste, Italy. Hepatology 1996;24:1926-311
   Google Scholar
• Zaya M, Hines R, Stevens J. Epirubicin glucuronidation and UGT2B7 developmental expression. Drug Metab Dispos 2006;34:2097-101
   PubMed Web of Science ®Google Scholar
• Collier A, Yamauchi Y, Sato B, et al. UDP-glucuronosyltransferase 1a enzymes are present and active in the mouse blastocyst. Drug Metab Dispos 2014;42:1921-5
   PubMedGoogle Scholar
• Burchell B, Coughtrie M, Jackson M, et al. Development of human liver UDP-glucuronosyltransferases. Dev Pharmacol Ther 1989;13:70-7
   PubMedGoogle Scholar
• Burchell B, Dutton GJ. Delayed induction by phenobarbital of UDP-glucuronyltransferase activity towards bilirubin in fetal liver. Biol Neonate 1975;26:122-8
   PubMedGoogle Scholar
• Hume R, Burchell A, Allan BB, et al. The ontogeny of key endoplasmic reticulum proteins in human embryonic and fetal red blood cells. Blood 1996;87:762-70
   PubMed Web of Science ®Google Scholar
• Cappiello M, Giuliani L, Rane A, et al. Uridine 5’-diphosphoglucuronic acid (UDPGLcUA) in the human fetal liver, kidney and placenta. Eur J Drug Metab Pharmacokinet 2000;25:161-3
   PubMed Web of Science ®Google Scholar
• Coughtrie M, Burchell B, Leakey JE, et al. The inadequacy of perinatal glucuronidation: immunoblot analysis of the developmental expression of individual UDP-glucuronosyltransferase isoenzymes in rat and human liver microsomes. Mol Pharmacol 1988;34:729-35
   PubMed Web of Science ®Google Scholar
• Freeze H. Congenital disorders of glycosylation and the pediatric liver. Semin Liver Dis 2001;21:501-15
   PubMed Web of Science ®Google Scholar
• Barone R, Sturiale L, Palmigiano A, et al. Glycomics of pediatric and adulthood diseases of the central nervous system. J Proteomics 2012;75:5123-39
   PubMed Web of Science ®Google Scholar
• Guillemette C. Pharmacogenomics of human UDP-glucuronosyltransferase enzymes. Pharmacogenomics J 2003;3:136-58
   PubMed Web of Science ®Google Scholar